Konstas, Anastasios G.
Holló, Gábor
Boboridis, Konstadinos G.
Funding for this research was provided by:
Open access funding provided by HEAL-Link Greece
Article History
Received: 9 July 2025
Accepted: 6 August 2025
First Online: 13 October 2025
Declarations
:
: Anastasios Georgios Konstas: research funding from Bayer, Omni Vision, Santen and Théa; fees for consultancy and lectures with travel support from Esteve, Intermed, Santen, Théa and Vianex. Gábor Holló has received fees from Théa for consultancy, and fees from Santen for consultancy and lectures with travel support. Konstadinos G. Boboridis has received fees from Alpha Intes, Théa, Bausch & Lomb and Santen for consultancy and lectures with travel support. Prof. Anastasios G. Konstas is an Editorial Board member of Advances in Therapy. He was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: Not applicable as this article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.